Mesoblast (MESO) Current Assets (2015 - 2025)
Mesoblast's (MESO) quarterly Current Assets came in at $202.5 million in Q4 2025, up 190.59% year-on-year from $69.7 million in Q4 2024, and down 0.91% quarter-over-quarter from $204.4 million in Q2 2025.
Mesoblast (MESO) Current Assets (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Current Assets across 11 years of filings, most recently posting $202.5 million for Q4 2025.
- Current Assets for Q4 2025 came in at $202.5 million, up 190.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $202.5 million (up 190.59% YoY), and the FY2025 annual result was $204.4 million, up 136.34% from the prior year.
- Current Assets came in at $202.5 million for Q4 2025 at Mesoblast, down from $204.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $204.4 million in Q2 2025 to a low of $61.4 million in Q1 2023.
- The 5-year median for Current Assets is $88.1 million (2022), against an average of $111.5 million.
- Across the five-year window, Current Assets sank 52.89% in 2022 and surged 190.59% in 2025, its largest moves.
- Mesoblast's Current Assets stood at $108.8 million in 2021, then retreated by 28.18% to $78.1 million in 2022, then advanced by 8.99% to $85.2 million in 2023, then dropped by 18.17% to $69.7 million in 2024, then surged by 190.59% to $202.5 million in 2025.
- The last three Current Assets figures came in at $202.5 million (Q4 2025), $204.4 million (Q2 2025), and $69.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 202.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 202.48 Mn |
| Jun 30, 2025 | 204.35 Mn |
| Dec 31, 2024 | 69.68 Mn |
| Jun 30, 2024 | 86.46 Mn |
| Dec 31, 2023 | 85.15 Mn |
| Jun 30, 2023 | 81.66 Mn |
| Mar 31, 2023 | 61.37 Mn |
| Dec 31, 2022 | 78.13 Mn |
| Sep 30, 2022 | 92.96 Mn |
| Jun 30, 2022 | 69.84 Mn |
| Mar 31, 2022 | 88.13 Mn |
| Dec 31, 2021 | 108.80 Mn |
| Sep 30, 2021 | 126.22 Mn |
| Jun 30, 2021 | 148.23 Mn |
| Mar 31, 2021 | 169.77 Mn |
| Dec 31, 2020 | 90.46 Mn |
| Sep 30, 2020 | 115.74 Mn |
| Jun 30, 2020 | 136.55 Mn |
| Mar 31, 2020 | 69.39 Mn |
| Dec 31, 2019 | 93.31 Mn |